Skip to main
CC
CC logo

Chemours (CC) Stock Forecast & Price Target

Chemours (CC) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 24%
Buy 24%
Hold 47%
Sell 6%
Strong Sell 0%

Bulls say

The Chemours Company is experiencing positive growth trajectories across its operating segments, particularly in Thermal & Specialized Solutions (TSS) where the adoption of HFO (Opteon) is driving sales growth and production expansion. Additionally, the Titanium Technologies (TT) segment is benefiting from year-over-year volume increases and a successful transformation initiative that has exceeded initial cost-saving expectations, potentially yielding up to $200 million by year-end. Moreover, Chemours is strategically positioned to capitalize on market dynamics in Europe, where anti-dumping measures may support volume recovery and stabilize pricing in the TiO2 market following recent cost forecasts.

Bears say

The Chemours Company faces significant challenges that contribute to a negative outlook on its stock, primarily due to anticipated destocking in its Advanced Performance Materials segment, which is expected to lag the TiO2 market downturn by 1-2 quarters. Further, the company has guided for a substantial decline in EBITDA in the fourth quarter, with the Titanium Technologies segment projected to experience a mid-high teens percentage drop, alongside weaker performance in Thermal & Specialized Solutions and stagnant results in Advanced Performance Materials. Additionally, mounting risks from declining TiO2 prices, regulatory slowdowns in demand for HFCs and HFOs, and weakening global macroeconomic conditions add further pressure to the company's financial stability.

Chemours (CC) has been analyzed by 17 analysts, with a consensus rating of Buy. 24% of analysts recommend a Strong Buy, 24% recommend Buy, 47% suggest Holding, 6% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Chemours and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Chemours (CC) Forecast

Analysts have given Chemours (CC) a Buy based on their latest research and market trends.

According to 17 analysts, Chemours (CC) has a Buy consensus rating as of Jul 12, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Chemours (CC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.